A Little 'Guidance': All You Need For Preemption?

Over the past decade, the the U.S. Food and Drug Administration has relied on guidance rather than formal note and comment rulemaking to achieve its regulatory aims and implement congressional mandates....

Already a subscriber? Click here to view full article